TY - JOUR
T1 - predicting the outcome for patients with myelofibrosis undergoingi an allogenic hemopoietic stem cell transplant
AU - Sora', Federica
PY - 2022
Y1 - 2022
N2 - Several predictive scores have been described for patients with myelofibrosis (MF): these include IPSS [1], DIPPS [2], MYSEC [3], MIPSS [4] and GIPSS [5]. All of these have in common the identification of clinical, and biological risk factors for evolution of the disease and death. When these prognostic scores are applied to patients undergoing a hemopoietic stem cell transplant (HSCT), the outcome reflects the progression of the disease: patients with an early disease, always do better than patients with more advanced disease, and/or a higher risk score
AB - Several predictive scores have been described for patients with myelofibrosis (MF): these include IPSS [1], DIPPS [2], MYSEC [3], MIPSS [4] and GIPSS [5]. All of these have in common the identification of clinical, and biological risk factors for evolution of the disease and death. When these prognostic scores are applied to patients undergoing a hemopoietic stem cell transplant (HSCT), the outcome reflects the progression of the disease: patients with an early disease, always do better than patients with more advanced disease, and/or a higher risk score
KW - predicting the outcome for patients with myelofibrosis
KW - predicting the outcome for patients with myelofibrosis
UR - http://hdl.handle.net/10807/218072
M3 - Article
SN - 2044-5385
SP - 111
EP - 111
JO - Blood Cancer Journal
JF - Blood Cancer Journal
ER -